Sir, The report from the Council of the British Cardiac Society (1984; 52: 679-82) quotes the Stanford experience and gives the one and five year survival figures as 63% and 39% respectively. Interestingly, these figures are virtually identical with the survival rates for a group of 169 patients with dilated cardiomyopathy (the principal indication for cardiac transplantation) who were treated medically at the Hammersmith Hospital. The one year and five year mortality rates of that group were reported to the British Cardiac Society as 34-7% and 59-4% respectively. '
Council's suggestion that cardiac transplantation prolongs life is, on this evidence, difficult to accept, particularly in view of the fact that on an "intention to treat" basis the surgical survival figures would be considerably worse-that is, because of the high early mortality in the sizeable group of clearly very sick patients who did not survive long enough to receive a transplant.
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